|
Treatment | Study type | Animal model | Cell source | Outcomes | References |
|
Growth factors and bioactive proteins | | | | | |
TGF-β1 | In vivo | Rat | — | Biomechanical strength↑ | Arimura et al. Am J Sports Med [59] |
TGF-β2 | In vitro | — | MSCs | Scx and Tnmd↑, N-cadherin and cadherin-11↓ | Theodossiou et al. Biochem Biophys Res Commun. [49] |
TGF-β3 | In vivo | Rat | — | Histological and biomechanical levels↑ | Han et al. Arthroscopy. [52] |
CTGF | In vitro and in vivo | Rat | TSPCs | Col I, Tnmd, Scx, and Tnc↑ in vitro and promoting tendon healing with well-aligned collagen fibers in vivo | Lee et al. J Clin Invest [58] |
GDF-5 | In vitro | — | BMSCs | Col I, Col III, Dcn, Scx, Tnc, and Tnmd↑ | Ciardulli et al. Int J Mol Sci [60] |
GDF-6 | In vitro and in vivo | Rat | BMSCs | Scx and Tnmd↑ in vitro and showing neotendon formation in vitro | Chai et al. Chin Med J (Engl). [61] |
GDF-6 and 7 | In vitro | — | ESCs | Tnc, Col I, and III↑ | Dale et al. Tissue Eng Part A. [36] |
GDF-8 | In vitro | — | BMSCs | Col 1A, Scx, and Tnmd ↑ | Le et al. J Hand Surg Asian Pac Vol [62] |
FGF-2 | In vitro and in vivo | Rat | TSPCs | Scx and Col III↑ in vitro and enhancing tendon healing in vivo | Guo et al. Biochem Biophys Res Commun [63] |
FGF-8b | In vitro | — | ASCs | Scx, Tnmd, and Tnc↓, Col I and III↓ | Otsuka et al. Stem Cell Res [64] |
TGF-β3 + BMP-12+ IGF1 + CTGF+FGF + AA | In vitro | — | MSCs | Scx↑ (induced by TGF-β3) and decorin↑ (induced by BMP-12, FGF and AA) | Perucca Orfei et al. Int J Mol Sci [65] |
Wnt ligands | In vitro | — | BMSCs | Tnmd, decorin, and Fmod↑ | Miyabara et al. J Equine Sci. [66] |
PRP | In vitro | — | Paratenon-derived cells | Scx and col I↑ | Imai et al. Sports Health [67] |
Gene modification | | | | | |
Transfection with BMP-12 and CTGF | In vitro and in vivo | Rat | TSPCs | Tnc, Col I and III↑ in vitro and presenting better outcome on histology level in vivo | Xu et al. J Biomech [68] |
Transfection with Scx | In vitro | — | BMSCs | Tnmd, Col I and several tendon-related matrix proteoglycans↑ | Alberton et al. Stem Cells Dev [69] |
Transfection with Mkx | In vitro | — | BMSCs | Tnmd, Tnc and Col I↑ | Otabe et al. J Orthop Res [70] |
Transfection with Egr1 | In vitro and in vivo | Rabbit | TSPC | Scx and Tnmd↑ in vitro and promoting rotator cuff repair in vivo | Tao et al. Cell Physiol Biochem [71] |
MiR-378a | In vitro and in vivo | Mice | TSPCs | Scx, Mkx, Fmod, Thbs4, Col I and III↓ in vitro, and Thbs4, Col I↓ in vivo | Liu et al. Stem Cell Res Ther [72] |
lncRNA H19 | In vitro and in vivo | Mice | TSPCs | Sxc, Mkx, Tnmd, Fmod, Dcn, and Col I↑ and enhancing tendon healing in vivo | Lu et al. FASEB J [73] |
Biomaterials | | | | | |
Tendon ECM-supplemented scaffold | In vitro | — | ASCs | Scx, Tnmd, and Tnc↑ | Yang et al. Biomaterials [74] |
Nanofiber and microfiber scaffolds | In vitro | — | Tendon fibroblasts | Cell number, total collagen and proteoglycan production↑ in nanofibers; Tnmd, Col I, III, and V↑ in microfibers | Erisken et al. Tissue Eng Part A [75] |
Mechanical stimulation | | | | | |
Dynamic stretch+ woven nanofibrous PCL scaffold | In vitro | — | ASCs, tenocytes, and HUVEC | Scx, Tnmd, Tnc, VEGFA, and Col I and III↑, as well as the total collagen content↑ | Wu et al. Acta Biomater [76] |
Uniaxial loading on 3D constructs | In vitro | — | TSPCs | Scx, Mkx, Tnmd, Col I I, and neotendon formation | Wang et al. FASEB journal [77] |
Cyclic tensile strain | In vitro | — | TSPCs | The expression of Col I, TNc, Tnmd, and Scx was most apparant at 0.5 Hz frequency with the same amplitude and at 4% amplitude with the same frequency | Xu et al. Biomed Res Int [78] |
|